Liquid Chromatographic Techniques for the Qualitative and Quantitative Analysis of Cyclosporine and Gingerol: Advances in Rheumatoid Arthritis Management

This review focuses on the advancements in liquid chromatographic techniques to do both qualitative and quantitative research on cyclosporine and gingerol, with particular emphasis on their incorporation into Novel Drug Delivery Systems (NDDS) to improve the management of Rheumatoid Arthritis (RA). The review underscores the importance of robust analytical methods for ensuring the precision, stability, and efficacy of these therapeutic agents in the context of RA. Despite the availability of conventional therapies, challenges such as poor bioavailability, rapid metabolism, and systemic toxicity persist. The combination of cyclosporine, a potent immunosuppressant, and gingerol, a natural anti-inflammatory compound, presents a promising approach to addressing these challenges and enhancing patient management in RA. Furthermore, this review explores the pathophysiology of RA, highlighting the need for specialised medication administration systems, such as nanocarriers, that optimize drug bioavailability and specifically target inflamed joints, thereby improving therapeutic outcomes. The role of liquid chromatography in the analysis and quality control of cyclosporine and gingerol is also discussed, with an emphasis on the development of analytical methods to support the advancement of NDDS for RA therapy.